Retrieve all available abstracts of the following 135 articles: HTML format
Single Articles
HJALMARSSON C, Lindgren M, Bergh N, Hornestam B, et al Atrial Fibrillation, Venous Thromboembolism, and Risk of Pulmonary Hypertension:
A Swedish Nationwide Register Study.
J Am Heart Assoc. 2025 May 2:e037418. doi: 10.1161/JAHA.124.037418. PubMed Abstract available
WU D, Xiong J, Huang Y, Yuan Y, et al Establishment of a lupus-prone mouse model of pulmonary arterial hypertension
with intermittent hypoxia: functional, biochemical and histological
verifications.
Clin Exp Hypertens. 2025;47:2500383. PubMed Abstract available
DAS BB Mechanism and Treatment of Right Ventricular Failure Due to Pulmonary
Hypertension in Children.
Children (Basel). 2025;12:476. PubMed Abstract available
ALTARABSHEH SE, Crestanello JA, Saran N, Daly RC, et al Impact of pulmonary hypertension and right ventricular function on outcomes of
isolated tricuspid valve surgery.
JTCVS Open. 2025;24:115-126. PubMed Abstract available
YANG B, Zaki A, Oh N, Umana-Pizano J, et al Role of a multidisciplinary team approach in the management of chronic
thromboembolic pulmonary hypertension.
JTCVS Open. 2025;24:147-155. PubMed Abstract available
JINNO S, Yamada A, Kawashima M, Izawa H, et al Clinical utility of right atrial strain to estimate pulmonary hypertension in
comparison with right ventricular free wall longitudinal strain.
Fujita Med J. 2025;11:86-90. PubMed Abstract available
SHIN A, Asaker JC, Abbott JD, Mullin CJ, et al Cardiac Tamponade in Pulmonary Hypertension: Management Using Right Heart
Catheterization Guidance.
J Soc Cardiovasc Angiogr Interv. 2025;4:102619. PubMed
YUAN Z, Wang Y, Wang J, Lai Y, et al Meta-analysis of targeted drugs for pulmonary hypertension to improve exercise
tolerance and associated factors in eisenmenger syndrome.
J Cardiothorac Surg. 2025;20:224. PubMed Abstract available
SCHAEFFER SF, Omer B, Vachharajani A, Panchangam C, et al Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension: Screening and
Management.
Neoreviews. 2025;26:e316-e327. PubMed Abstract available
YU Y, Wang Y, Yang Z, Li Z, et al Methyleugenol alleviates pulmonary vascular remodeling in rats with high-altitude
pulmonary hypertension by improving pulmonary smooth muscle cell function.
Biomed Pharmacother. 2025;187:118109. PubMed Abstract available
SANTI A, Ngah V, Robbins EW, Maron BA, et al The Heterogeneity of Pulmonary Hypertension Nomenclature in Empiric Research
Studies: Systematic Findings From Three Western European Countries.
Pulm Circ. 2025;15:e70089. PubMed Abstract available
LI J, Wan J [Pulmonary vascular interventions: innovating through adaptation and advancing
through differentiation].
Zhonghua Jie He He Hu Xi Za Zhi. 2025;48:401-404. PubMed Abstract available
CRINER RN, Naranjo M, D'Alonzo G, Weaver S, et al Pulmonary Hypertension-Related Interstitial Lung Disease: An Expert Opinion with
a Real-World Approach.
Biomedicines. 2025;13:808. PubMed Abstract available
RYSZKIEWICZ P, Schlicker E, Malinowska B Is Inducible Nitric Oxide Synthase (iNOS) Promising as a New Target Against
Pulmonary Hypertension?
Antioxidants (Basel). 2025;14:377. PubMed Abstract available
FU H, Geng L, Chen J, Fan Q, et al Postoperative Care of a Paediatric Patient With Common Arterial Trunk Associated
With Ventricular Septal Defect and Pulmonary Arterial Hypertension: A Rare Case
Report.
Nurs Crit Care. 2025;30:e70048. PubMed Abstract available
KOGA Y, Tahara N, Sugiyama Y, Maeda-Ogata S, et al Glucose and insulin actions after glucose loading on myocardial glucose
metabolism in pulmonary hypertension.
Eur Heart J Imaging Methods Pract. 2025;3:qyaf044. PubMed
SARA JDS, Ishikawa K, Li Y, Anisuzzaman DM, et al Acoustic features are independently associated with heart failure and pulmonary
hypertension.
ESC Heart Fail. 2025 Apr 28. doi: 10.1002/ehf2.15309. PubMed Abstract available
LORENZATTI D, Motwani M Cardiovascular magnetic resonance in pulmonary hypertension: Keeping it simple.
Prog Cardiovasc Dis. 2025 Apr 26:S0033-0620(25)00064. PubMed
JANSA P, Sadushi-Kolici R, Skoro-Sajer N, Kopec G, et al Long-Term Treatment With Subcutaneous Treprostinil in Patients With Severe
Inoperable Chronic Thromboembolic Pulmonary Hypertension in the Multimodal
Therapy Era (Data From CTREPH Study Open Label Extension).
Pulm Circ. 2025;15:e70080. PubMed Abstract available
TONDO P, Tricarico L, Galgano G, Varlese MPC, et al Utility of Clustering in Mortality Risk Stratification in Pulmonary Hypertension.
Bioengineering (Basel). 2025;12:408. PubMed Abstract available
KOMORI T, Sato T, Tsujino I, Tamatsuki D, et al Two cases of bronchial artery aneurysms in patients with long-standing
precapillary pulmonary hypertension.
Respir Investig. 2025;63:521-523. PubMed Abstract available
MOSCATELLI A, Buffoni I, Derchi ME, Bagnasco F, et al Ductus Arteriosus Patency for the Hemodynamic Management of Newborns With
Pulmonary Hypertension on Veno-Venous Extracorporeal Membrane Oxygenation.
ASAIO J. 2025 Apr 25. doi: 10.1097/MAT.0000000000002437. PubMed Abstract available
BEHRENDT PO, Ley L, Ghofrani HA, Bandorski D, et al Bradycardias in Patients with Pulmonary Hypertension-Prevalence, Pathophysiology
and Clinical Relevance.
J Cardiovasc Dev Dis. 2025;12:120. PubMed Abstract available
BUTROUS G Global Landscape of Infection-Induced Pulmonary Hypertension.
Infect Dis Rep. 2025;17:35. PubMed Abstract available
XIONG J, Chen J, Zhou J, Li C, et al Exploring hypoxia driven subtypes of pulmonary arterial hypertension through
transcriptomics single cell sequencing and machine learning.
Sci Rep. 2025;15:14251. PubMed Abstract available
LUO G, Wan H, Ji ZX, Ren YY, et al [Clinical analysis and follow-up study of transcatheter closure of secundum
atrial septal defect in infants].
Zhonghua Er Ke Za Zhi. 2025;63:518-523. PubMed Abstract available
KEAM SJ Macitentan: Pediatric First Approval.
Paediatr Drugs. 2025;27:377-382. PubMed Abstract available
LV X, Tang M, Li W, Liu K, et al A predictive model for early postoperative hypoxemia after mitral valve
replacement combined with pulmonary arterial hypertension.
Surgery. 2025;181:109280. PubMed Abstract available
HIGHLAND KB, Chakravarty R, Georgi S, Han M, et al Patient Perspectives and Clinical Insights Into the Diagnostic Journey From
Connective Tissue Disease to Pulmonary Arterial Hypertension.
J Rheumatol. 2025 Feb 20:jrheum.2024-0613. doi: 10.3899/jrheum.2024-0613. PubMed
AYYAD SIE, Refeat MM, Ashaat EA, Abdel-Ghaffar AB, et al Genetic screening in cohort of Egyptian patients with pulmonary arterial
hypertension disease.
Ir J Med Sci. 2025;194:641-648. PubMed Abstract available
MOHAMED NF, Zaki El Feky OAEF, Saad El Din El Ganady HM, Abd El Halim WAE, et al Comparative study between nebulized and intravenous magnesium sulfate for
treatment of persistent pulmonary hypertension in neonates.
J Neonatal Perinatal Med. 2025;18:246-254. PubMed Abstract available
LEE MH, Menezes TCF, Reisz JA, Cendali FI, et al Physiologic relevance of the transpulmonary metabolome in connective tissue
disease-associated pulmonary vascular disease.
JCI Insight. 2025;10:e187911. PubMed Abstract available
WIEWIORA M, Nowowiejska-Wiewiora A, Gasior M, Piecuch J, et al Noncardiac surgery for severe pulmonary hypertension: two surgeries in one
patient and a review of the literature.
Ann Med Surg (Lond). 2025;87:2963-2969. PubMed Abstract available
DE PINTO M, Spinella A, Cerri S, Orlandi M, et al Role of COVID-19 in the Progression of Scleroderma Interstitial Lung Disease and
New Onset Pulmonary Hypertension: A Challenging Case Report.
Respirol Case Rep. 2025;13:e70197. PubMed Abstract available
SUN C, Wen Y, Chen Y Successful treatment of pulmonary hypertension due to HIV infection and
amphetamine snorting: a case report.
Front Med (Lausanne). 2025;12:1556041. PubMed Abstract available
LOVEY O, Garin N, Geiser-Hirschler A [Not Available].
Rev Med Suisse. 2025;21:990-992. PubMed
YUEN AD, Zaffiri L, Tapson V, Rampolla R, et al Use of Inhaled Treprostinil in Lung Transplant Candidates With Pulmonary
Hypertension Associated With Interstitial Lung Disease.
Respir Care. 2025 May 7. doi: 10.1089/respcare.12900. PubMed
YEGAMBARAM M, Pokharel MD, Sun X, Lu Q, et al Restoration of pp60(Src) Re-Establishes Electron Transport Chain Complex I
Activity in Pulmonary Hypertensive Endothelial Cells.
Int J Mol Sci. 2025;26:3815. PubMed Abstract available
LI M, Zhang W, Zhang M, Li L, et al LONP1 facilitates pulmonary artery smooth muscle cell glycolytic reprogramming by
degrading MPC1 in pulmonary hypertension.
Clin Sci (Lond). 2025 May 7:CS20255922. doi: 10.1042/CS20255922. PubMed Abstract available
VOLKOV AV, Yudkina NN, Nasonov EL Long-Term Prospective Observation Study of Patients with Pulmonary Arterial
Hypertension Associated with Connective Tissue Diseases.
Kardiologiia. 2025;65:23-30. PubMed Abstract available
GUARNIERI G, Briguglia D, Conte E, Andreini D, et al Pulmonary embolism with pulmonary hypertension or something far worse? Unveiling
a rare and lethal pulmonary artery angiosarcoma: a case report.
Eur Heart J Case Rep. 2025;9:ytaf207. PubMed Abstract available
LI L, Zhou W, Ji Q, Zhang X, et al Role of MiR-542-3p/Integrin-Linked Kinase/Myocardin Signaling Axis in Hypoxic
Pulmonary Hypertension.
Pulm Circ. 2025;15:e70094. PubMed Abstract available
BUTROUS G Pulmonary hypertension aetiologies in different parts of the world.
Int J Cardiol Congenit Heart Dis. 2025;20:100586. PubMed Abstract available
YAMASHITA S, Hiraide T, Shiraishi Y, Katsumata Y, et al Exercise hemodynamic evaluation in the management of dasatinib-related pulmonary
arterial hypertension: a case report.
J Med Case Rep. 2025;19:209. PubMed Abstract available
DAVIS S, Skalicky A, Beaudet A, Bayer B, et al Validation of the Pulmonary Arterial Hypertension-Symptoms and Impact for
Clinical Use (SYMPACT-CP): a qualitative interview study.
BMC Pulm Med. 2025;25:217. PubMed Abstract available
SATI SK, Rana U, Joshi C, Teng RJ, et al Decreased endothelial micro-RNA-30b-5p impairs angiogenesis in fetal lambs with
persistent pulmonary hypertension.
Pediatr Res. 2025 May 6. doi: 10.1038/s41390-025-04098. PubMed Abstract available
OSOKINA AK, Rodnenkov OV, Martynyuk TV [Historical milestones in the study of pulmonary hypertension].
Ter Arkh. 2025;97:289-295. PubMed Abstract available
CHAZOVA IE, Martynyuk TV, Avdeev SN, Valieva ZS, et al [Expert consensus on approaches to risk stratification and choice of therapy in
patients with inoperable and residual chronic thromboembolic pulmonary
hypertension].
Ter Arkh. 2025;97:279-288. PubMed Abstract available
SHOGENOVA LV [Efficiency and safety of the integrated use of medical gases thermal heliox,
nitric oxide and molecular hydrogen in patients with exacerbation of chronic
obstructive pulmonary disease complicated by hypoxemic, hypercapnic respiratory
failure and seco
Ter Arkh. 2025;97:242-249. PubMed Abstract available
HUNGERFORD S, Kapur N, Rich S, Burkhoff D, et al The pulmonary resistance-compliance relationship: Real or mathematical artifact?
Physiol Rep. 2025;13:e70355. PubMed Abstract available
O'NEILL E, Lu DY, Ramakrishna S, Ingram D, et al Methamphetamine-Associated Pulmonary Arterial Hypertension Is Associated With
Worse Right Ventricular Function Than Idiopathic Pulmonary Arterial Hypertension:
A Matched Study.
Echocardiography. 2025;42:e70180. PubMed Abstract available
PAUDYAL V, Thapa R, Basnet S, Sharma M, et al Updates on Pulmonary Hypertension.
Open Respir Med J. 2025;19:e18743064344024. PubMed Abstract available
AYDIN S, Temur B, Tire Y, Ilgaz Kocyigit O, et al [MSB-43] Pulmonary Endarterectomy in Chronic Thromboembolic Pulmonary
Hypertension: Our Initial Experience.
Turk Gogus Kalp Damar Cerrahisi Derg. 2024;32. PubMed Abstract available
OKOYE AG, Khawash A, Nanjundappa M, Jones M, et al Persistent pulmonary hypertension of the newborn infant (PPHN) due to premature
closure of the ductus arteriosus (DA).
Case Rep Perinat Med. 2024;13:20240001. PubMed Abstract available
LE BON CHAMI B, Charif F, Semaan C, Bironneau V, et al Pulmonary Arterial Hypertension-approved drugs in Pulmonary Hypertension
associated with COPD: A systematic literature review.
Respir Med Res. 2025;87:101165. PubMed Abstract available
ABRAMOV AA, Lakomkin VL, Prosvirnin AV, Kuzmin VS, et al Pulmonary Arterial Hypertension Induces Compensatory Increase of Left Ventricular
Contractility Indexes in Rats in Response to Its Filling Insufficiency.
Bull Exp Biol Med. 2025;178:586-592. PubMed Abstract available
PAEZ-CARPIO A, Cornellas L, Domenech-Ximenos B, Serrano E, et al Non-contrast dual-energy CT iodine quantification for lung injury
characterization after balloon pulmonary angioplasty.
Eur J Radiol. 2025;187:112129. PubMed Abstract available
YUAN M, Hu X, Xing W, Wu X, et al Corrigendum to: B2M is a Biomarker Associated With Immune Infiltration In High
Altitude Pulmonary Edema.
Comb Chem High Throughput Screen. 2025;28:913. PubMed Abstract available
XU C, Bao Y, Ding H, Wang K, et al The association between antenatal indomethacin exposure and persistent pulmonary
hypertension of the newborn in extremely preterm infants.
Sci Rep. 2025;15:16962. PubMed Abstract available
LEIVA O, Soo S, Liu O, Smilowitz NR, et al Characterization and prognostic implication of pulmonary hypertension among
patients with myeloproliferative neoplasms.
Haematologica. 2025 May 15. doi: 10.3324/haematol.2025.287497. PubMed Abstract available
VARIAN F, Burney R, Pearson C, Goh ZM, et al Selection of patient-reported outcome measures in pulmonary arterial hypertension
clinical trials: a systematic review, meta-analysis and health-related quality of
life framework.
Eur Respir Rev. 2025;34:250006. PubMed Abstract available
KRUSZONA S, Aburahma K, de Manna ND, Bobylev D, et al Pulmonary Hypertension and Lung Transplantation.
Zentralbl Chir. 2025 May 14. doi: 10.1055/a-2590-2620. PubMed Abstract available
MARGOLIS G, Hafner OM, Kazatsker M, Roguin A, et al Pre-Existing Pulmonary Hypertension Impact on In-Hospital Outcomes of Cardiac
Implantable Electrical Device Implantation.
JACC Adv. 2025;4. PubMed Abstract available
GABIZON-PERETZ S, Yerushalmi R, Vaturi M, Nardi Agmon I, et al Emergent Pulmonary Hypertension and Right Ventricular Impairment Following
Gemcitabine Therapy for Metastatic Breast Cancer.
Isr Med Assoc J. 2025;27:319-321. PubMed
BAI J, He S, Wang X, Zhang L, et al Mitochondrial Genome-Encoded lncND5 Regulates Mitophagy in Hypoxic Pulmonary
Artery Smooth Muscle Cell.
FASEB J. 2025;39:e70618. PubMed Abstract available
DAI J, Chen H, Fang J, Wu S, et al Vascular Remodeling: The Multicellular Mechanisms of Pulmonary Hypertension.
Int J Mol Sci. 2025;26:4265. PubMed Abstract available
CHENG HF, Chang YP, Chai JW Investigating Patients with Pulmonary Hypertension Under Detector-Based Spectral
Computed Tomography.
Diagnostics (Basel). 2025;15:1069. PubMed Abstract available
PAPADOPOULOS GE, Arvanitaki A, Mouratoglou SA, Gourgiotis P, et al Prognosis and Treatment With Phosphodiesterase 5 Inhibitors in Combined Post- and
Precapillary Pulmonary Hypertension: A Propensity Score-Matched Analysis From the
Hellenic Pulmonary Hypertension Registry.
Pulm Circ. 2025;15:e70099. PubMed Abstract available
VERHAEGEN J, Willems L, Wagenaar A, Spreuwers R, et al Endothelial Features Along the Pulmonary Vascular Tree in Chronic Thromboembolic
Pulmonary Hypertension: Distinctive or Shared Facets?
Pulm Circ. 2025;15:e70096. PubMed Abstract available
NIGLAS M, Baxan N, Ashek A, Zhao L, et al Automated Bi-Ventricular Segmentation and Regional Cardiac Wall Motion Analysis
for Rat Models of Pulmonary Hypertension.
Pulm Circ. 2025;15:e70092. PubMed Abstract available
SALEHI M, Alabed S, Sharkey M, Maiter A, et al Artificial intelligence-based echocardiography assessment to detect pulmonary
hypertension.
ERJ Open Res. 2025;11:00592-2024. PubMed Abstract available
DZUDOVIC B, Djuric I, Matijasevic J, Jovic Z, et al Coronary-type stent implantation in chronic thromboembolic pulmonary
hypertension: a national registry case series.
Cardiol J. 2025 May 13. doi: 10.5603/cj.103142. PubMed Abstract available
SAKURAI M, Hosokawa S, Yamaguchi Y, Kirimura S, et al Cyclopamine Attenuates Pulmonary Arterial Hypertension Development: Implications
of Hedgehog Signaling Involvement for the Pathophysiology.
FASEB J. 2025;39:e70628. PubMed Abstract available
WIDJAJA SL, Anniazi ML, Artiko B, Moelyo AG, et al BMPR-II, caspase-3, HIF-1alpha, and VE-cadherin profile in Down syndrome children
with and without congenital heart disease and pulmonary hypertension.
Narra J. 2025;5:e1244. PubMed Abstract available
SOFIA SN, Bahrudin U, Uddin I, Sobirin MA, et al Role of phosphodiesterase-3 inhibitor in cardiorespiratory fitness and functional
class of patients with pulmonary hypertension: A randomized, double-blind,
placebo-controlled trial.
Narra J. 2025;5:e1301. PubMed Abstract available
KNAUSS HM, Ambatipudi M, Kosyakovsky LB, Herzig MS, et al Trans-right ventricle metabolite gradients in obesity highlight multiple
metabolic pathways.
Physiol Rep. 2025;13:e70323. PubMed Abstract available
XIONG XJ [Connotation of deficiency-induced chest impediment and Renshen Decoction based
on severe cases and modern pathophysiological mechanisms and its application in
treatment of coronary heart disease, rheumatic heart disease, heart failure,
hypotension, p
Zhongguo Zhong Yao Za Zhi. 2025;50:1706-1714. PubMed Abstract available
HAN J, Wang L, Wang L, Lei H, et al 5-Hydroxytryptamine Limits Pulmonary Arterial Hypertension Progression by
Regulating Th17/Treg Balance.
Biol Pharm Bull. 2025;48:555-562. PubMed Abstract available
KIM HC, King CS, Thomas C, Khangoora V, et al Physician perspectives on pulmonary hypertension in ILD: results of a cases-based
survey.
BMC Pulm Med. 2025;25:231. PubMed Abstract available
DONG Z, Xue Z, Zhang M, Wang L, et al Lingguizhugan decoction inhibit pulmonary hypertension by regulating macrophage
IL-6 secretion via IL-33/ST2 pathway.
Phytomedicine. 2025;143:156822. PubMed Abstract available
NAGAOKA T Inhaled treprostinil for pulmonary hypertension due to interstitial lung disease.
Respir Investig. 2025;63:608-609. PubMed
CARDOSO NL, de Sa JF, do Nascimento LFE, Mendes LA, et al Psychometric properties of the sit-to-stand test for patients with pulmonary
hypertension: A systematic review.
Braz J Phys Ther. 2025;29:101223. PubMed Abstract available
JIAO Q, Xu X, Xu L, Wang Y, et al Knockdown of eIF3a alleviates pulmonary arterial hypertension by inhibiting
endothelial-to-mesenchymal transition via TGFbeta1/SMAD pathway.
J Transl Med. 2025;23:524. PubMed Abstract available
KLOUDA T, Tsikis ST, Hirsch TI, Kim Y, et al Smooth muscle Cxcl12 contributions to vascular remodeling in flow and
hypoxia-induced pulmonary hypertension.
J Biol Chem. 2025 May 7:110207. doi: 10.1016/j.jbc.2025.110207. PubMed Abstract available
LARSEN BS, Biering-Sorensen T, Olsen FJ Exploring the Link Between Left Atrial Strain and Exercise-Induced Pulmonary
Hypertension.
Echocardiography. 2025;42:e70187. PubMed
HARMON AC, Carroll-Turpin MA, Jennings MH, Jelesijevic T, et al Environmental Aromatic Amine Induces Pulmonary Arterial Hypertension Associated
With Estrogen Signaling and Serpine1.
J Appl Toxicol. 2025;45:948-963. PubMed Abstract available
LIU X, Tan X, Su Y, Zou L, et al Anthocyanin attenuates pulmonary arterial hypertension and associated heart
failure via improving mitochondrial function through Nrf2-dependent mechanism.
Clin Exp Hypertens. 2025;47:2503805. PubMed Abstract available
JAKUBOWSKI B, Yager A, Madsen K, Schwalk A, et al Safety of Robotic-Assisted Bronchoscopy for Pulmonary Lesions in Patients With
Pulmonary Hypertension on Vasodilator Therapy: A Single-Centre Experience.
Respirol Case Rep. 2025;13:e70205. PubMed Abstract available
MERCAN R, Gokten DB, Kara SP, Uzum NM, et al Can mac-2 binding protein glycosylation isomer serve as a biomarker for
predicting pulmonary arterial pressure and pulmonary hypertension in systemic
sclerosis?
Turk J Med Sci. 2025;55:404-412. PubMed Abstract available
MATTA A, Polychronopoulou E, Kuo YF, Sharma G, et al Pulmonary rehabilitation utilization in patients with chronic respiratory
diseases: 2014-2019.
Respir Med. 2025;242:108110. PubMed Abstract available
XU D, Liu H, Yang J Assessing causal relationships between gut microbiotas, metabolites, and
pulmonary arterial hypertension through univariate Mendelian randomization study
and bioinformatics analysis.
J Hypertens. 2025 Mar 19. doi: 10.1097/HJH.0000000000004003. PubMed Abstract available
GUO X, Qian J, Lai J, Wang H, et al Predictive value of pulmonary to systemic vascular resistance ratio in systemic
lupus erythematosus patients with pulmonary arterial hypertension.
J Hypertens. 2025 Mar 21. doi: 10.1097/HJH.0000000000004010. PubMed Abstract available
ZENG X, Ma Z, Wen S, Zhou L, et al Imatinib aggravates pressure-overload-induced right ventricle failure via
JNK/Runx2 pathway.
Br J Pharmacol. 2025;182:2560-2581. PubMed Abstract available
HOU J, Liu K, Zhang MJ, Xu XH, et al Integrated Transcriptomic and Metabolomic Analysis of Rat PASMCs Reveals the
Underlying Mechanism for Pulmonary Arterial Hypertension.
Am J Hypertens. 2025 Feb 4:hpaf015. doi: 10.1093. PubMed Abstract available
ZHANG M, Bu C, Jiang K, Long X, et al Image Findings from Dual-phase Computed Tomography Pulmonary Angiography for
Diagnosing Tuberculosis-associated Fibrosing Mediastinitis.
Curr Med Imaging. 2025;21:e15734056324457. PubMed Abstract available
KERN AL, Park DH, Fuge J, Hohlfeld JM, et al Loss of pulmonary capillaries in idiopathic pulmonary arterial hypertension with
low diffusion capacity is accompanied by early diffuse emphysema detected by
(129)Xe MRI.
Eur Radiol. 2025;35:3010-3020. PubMed Abstract available
CALDEIRA D, Cazeiro DI, Placido R, Ferreira F, et al The Placebo Effect in Chronic Thromboembolic Pulmonary Hypertension Trials: A
Systematic Review and Meta-Analysis.
Med Sci (Basel). 2025;13:57. PubMed Abstract available
ESTRADA RA, Sahay S, Tonelli AR Treatment of pulmonary hypertension after seven world symposia.
Ther Adv Respir Dis. 2025;19:17534666251342898. PubMed Abstract available
TANIGUCHI Y, Sakamoto M, Fujii H, Miwa K, et al Nocturnal desaturation in patients with non-operable chronic thromboembolic
pulmonary hypertension.
BMC Pulm Med. 2025;25:254. PubMed Abstract available
PHAM AT, Virk S, Oliveira AC, Alves MD, et al Opposing role for myeloid and smooth muscle cell STING in pulmonary hypertension.
JCI Insight. 2025 May 22:e184792. doi: 10.1172/jci.insight.184792. PubMed Abstract available
PARIKH K Pulmonary hypertension in 2025: next steps?
Curr Opin Cardiol. 2025 May 2. doi: 10.1097/HCO.0000000000001228. PubMed Abstract available
LEE PL, Acero LMR, Nanna M Ultrasound-Based assessment of systemic congestion in pulmonary hypertension.
Curr Opin Cardiol. 2025 May 2. doi: 10.1097/HCO.0000000000001227. PubMed Abstract available
LIU B, Yi D, Li S, Ramirez K, et al Single-Cell and Spatial Transcriptomics Identified Fatty Acid-Binding Proteins
Controlling Endothelial Glycolytic and Arterial Programming in Pulmonary
Hypertension.
Arterioscler Thromb Vasc Biol. 2025 May 22. doi: 10.1161/ATVBAHA.124.321173. PubMed Abstract available
AHMADIPOUR B, Isfahani MH, Abaszadeh S, Hassanpour H, et al Dietary L-carnitine modulates oxidative stress, lipid metabolism, and pulmonary
hypertension in chickens raised at high-altitude under cold stress.
BMC Vet Res. 2025;21:369. PubMed Abstract available
ZHANG J, Luo MY, Li NP, Liang N, et al Histone lactylation-derived prelamin A accelerates pulmonary arterial smooth
muscle cells senescence in hypoxia-induced pulmonary hypertension rats.
Int Immunopharmacol. 2025;159:114871. PubMed Abstract available
MIRA JJ, Torres DG, Santina M Patient experience with pulmonary hypertension in Spain.
Orphanet J Rare Dis. 2025;20:239. PubMed Abstract available
LIN Y, Li M, Xie S Diagnostic value of fully automated CT pulmonary angiography in patients with
chronic thromboembolic pulmonary hypertension and chronic thromboembolic disease.
Eur Radiol. 2025 May 20. doi: 10.1007/s00330-025-11698. PubMed Abstract available
BAEK K, Kim M, Seo M, Jung JW, et al Evaluation of the left ventricular eccentricity index for assessing dogs
classified by pulmonary hypertension probability.
Am J Vet Res. 2025 May 20:1-8. doi: 10.2460/ajvr.24.11.0339. PubMed Abstract available
CONG Y, Sun N, Deng RW, Wu BX, et al [Current researches and influencing factors of health-related quality of life in
patients with pulmonary hypertension].
Zhonghua Xin Xue Guan Bing Za Zhi. 2025;53:547-552. PubMed
COSKUN M, Yildirim A, Cetin AE, Pacaci E, et al Peripheral venous pressure measurements to evaluate congestion in pulmonary
arterial hypertension.
Medicine (Baltimore). 2025;104:e42422. PubMed Abstract available
LU M, Wang B, Rong C, Wang Y, et al Therapeutic challenges and new therapeutic targets for combined capillary
pulmonary hypertension: a review.
Front Med (Lausanne). 2025;12:1579112. PubMed Abstract available
YANG N, Huayu M, Su S, Hou B, et al Bioactive compound combinations from Rhodiola tangutica alleviate pulmonary
vascular remodeling in high-altitude pulmonary hypertension rats through the
PI3K-AKT pathway.
Front Pharmacol. 2025;16:1582677. PubMed Abstract available
SHINYA Y, Kimura M, Momoi M, Hiraide T, et al Efficacy and Long-term Mortality after Balloon Pulmonary Angioplasty in Older
Patients with Chronic Thromboembolic Pulmonary Hypertension.
Can J Cardiol. 2025 May 15:S0828-282X(25)00340. PubMed Abstract available
ANTIGNY F, Luo R, Perrier R, Masson B, et al Ca(2+) Cycling Alteration in a Porcine Model of Right Ventricular Dysfunction.
Circ Heart Fail. 2025;18:e012293. PubMed Abstract available
CHEN Y, Chen Z, Liang L, Li J, et al Multi-kingdom gut microbiota dysbiosis is associated with the development of
pulmonary arterial hypertension.
EBioMedicine. 2025;115:105686. PubMed Abstract available
ROTHMAN AMK, Florentin A, Zink F, Quigley C, et al Therapeutic potential of allosteric HECT E3 ligase inhibition.
Cell. 2025;188:2603-2620. PubMed Abstract available
SUNTHARALINGAM J, Toshner MR, Blacker K, Howard LS, et al How Can We Ensure Accessible and High-Quality Specialist Care for Pulmonary
Hypertension Patients?
Am J Respir Crit Care Med. 2025. PubMed
BOUCLY A, Song S, Keles M, Wang D, et al Clustering Pulmonary Hypertension Patients Using the Plasma Proteome.
Am J Respir Crit Care Med. 2025. PubMed Abstract available
BORDAG N, Nagy BM, Zugner E, Ludwig H, et al Lipid Ratios for Diagnosis and Prognosis of Pulmonary Hypertension.
Am J Respir Crit Care Med. 2025. PubMed Abstract available
BAILEY M, Frantz R, Minhas J, Cascino T, et al The frequency and predictors of pulmonary rehabilitation referrals among patients
with pulmonary arterial hypertension: An analysis of the Pulmonary Hypertension
Association Registry.
Chest. 2025 Apr 28:S0012-3692(25)00547-1. doi: 10.1016/j.chest.2025. PubMed Abstract available
MCCARTHY BE, Feng R, Torigian DA, Tong Y, et al Epicardial Adipose Tissue as an Independent Risk Factor for Mortality in
Pulmonary Arterial Hypertension.
Chest. 2025;167:1481-1492. PubMed Abstract available
MATUSOV Y, Kolaitis NA, Geft D, DesJardin J, et al How I do it: Best practices for right heart catheterization in the diagnosis of
pulmonary hypertension.
Chest. 2025 May 16:S0012-3692(25)00579-3. doi: 10.1016/j.chest.2025. PubMed Abstract available
ZHAKEER G, Zeng Y, E G, Maimaitiaili N, et al T(reg) Cells Attenuate Pulmonary Venous Remodeling in PH-LHD via NLRC3 Signaling.
Circ Res. 2025;136:e113-e128. PubMed Abstract available
QIU F, Miao HR, Hui HL, Qiu LJ, et al MHCII(hi)LYVE1(lo)CCR2(hi) Interstitial Macrophages Promote Medial Fibrosis in
Pulmonary Arterioles and Contribute to Pulmonary Hypertension.
Circ Res. 2025 May 13. doi: 10.1161/CIRCRESAHA.125.326173. PubMed Abstract available
YU Q, Tai YY, Tang Y, Zhao J, et al Correction to: BOLA (BolA Family Member 3) Deficiency Controls Endothelial
Metabolism and Glycine Homeostasis in Pulmonary Hypertension.
Circulation. 2025;151:e967. PubMed
BALMAIN BN, Babb TG Reply to: Unravelling the physiology of exercise pulmonary hypertension in
patients with heart failure with preserved ejection fraction.
Eur Respir J. 2025;65:2500543. PubMed
JHA AK Unravelling the physiology of exercise pulmonary hypertension in patients with
heart failure with preserved ejection fraction.
Eur Respir J. 2025;65:2500384. PubMed
BOUCLY A, Montani D, Bauer F, Artaud-Macari E, et al Initial therapy in patients with pulmonary arterial hypertension and
cardiovascular comorbidities.
Eur Respir J. 2025;65:2400895. PubMed Abstract available
HOEPER MM, Gomberg-Maitland M, Badesch DB, Gibbs JSR, et al Efficacy and safety of the activin signalling inhibitor, sotatercept, in a pooled
analysis of PULSAR and STELLAR studies.
Eur Respir J. 2025;65:2401424. PubMed Abstract available
MESERVEY A, Al-Naamani N, Minhas J, Fritz JS, et al Renal dysfunction and outcomes in pulmonary arterial hypertension and chronic
thromboembolic pulmonary hypertension: an individual participant data
meta-analysis.
Eur Respir J. 2025 May 22:2402400. doi: 10.1183/13993003.02400-2024. PubMed Abstract available
SELMAN M, Buendia-Roldan I, Pardo A Decoding the complexity: mechanistic insights into comorbidities in idiopathic
pulmonary fibrosis.
Eur Respir J. 2025;65:2402418. PubMed Abstract available
WREN JT JR, Patel N, Harting MT, McNamara PJ, et al Hemodynamic precision to guide surgical timing for neonates with congenital
diaphragmatic hernia: a narrative review.
J Perinatol. 2025 Mar 19. doi: 10.1038/s41372-025-02265. PubMed Abstract available
BHATT DR, Braun D, Dizon RA, Shi JM, et al Retrospective study of preterm infants exposed to inhaled nitric oxide in Kaiser
Permanente Southern California: morbidity, mortality and follow-up.
J Perinatol. 2024 Jul 18. doi: 10.1038/s41372-024-02051. PubMed Abstract available
KHOR YH, Palm A, Wong AW, Guler SA, et al Effects of long-term oxygen therapy on acute exacerbation and hospital burden:
the national DISCOVERY study.
Thorax. 2025;80:378-384. PubMed Abstract available
MIDDLETON RC, Karpov OA, Fournier M, Kreimer S, et al Impact of cardiosphere-derived cells on the maladapted right ventricular muscle
in a rat sugen/hypoxia model of pulmonary hypertension with right ventricular
dysfunction.
PLoS One. 2025;20:e0321895. PubMed Abstract available
